Paul F Urrutia
Examiner (ID: 8172)
Art Unit(s) | OPLC |
Total Applications | 5 |
Issued Applications | 0 |
Pending Applications | 5 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 15726783
[patent_doc_number] => 10611813
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-07
[patent_title] => Method of production of human insulin methyl ester
[patent_app_type] => utility
[patent_app_number] => 15/106689
[patent_app_country] => US
[patent_app_date] => 2014-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 2516
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15106689
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/106689 | Method of production of human insulin methyl ester | Dec 21, 2014 | Issued |
Array
(
[id] => 10220327
[patent_doc_number] => 20150105320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'ANTI-ANGIOGENIC TREATMENT OF OVARIAN, BREAST, AND PROSTATE CANCER WITH A COMBINATION OF ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 14/575266
[patent_app_country] => US
[patent_app_date] => 2014-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11569
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14575266
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/575266 | Anti-angiogenic treatment of endothelial tissue with a combination of antagonists | Dec 17, 2014 | Issued |
Array
(
[id] => 10289196
[patent_doc_number] => 20150174194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'METHODS FOR TREATING LIVER TRANSPLANT RECIPIENTS'
[patent_app_type] => utility
[patent_app_number] => 14/574654
[patent_app_country] => US
[patent_app_date] => 2014-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2858
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14574654
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/574654 | METHODS FOR TREATING LIVER TRANSPLANT RECIPIENTS | Dec 17, 2014 | Abandoned |
Array
(
[id] => 13803867
[patent_doc_number] => 10179194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-15
[patent_title] => Self-assembling peptides, peptidomimetics and peptidic conjugates as building blocks for biofabrication and printing
[patent_app_type] => utility
[patent_app_number] => 15/039952
[patent_app_country] => US
[patent_app_date] => 2014-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 26502
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15039952
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/039952 | Self-assembling peptides, peptidomimetics and peptidic conjugates as building blocks for biofabrication and printing | Nov 30, 2014 | Issued |
Array
(
[id] => 11364060
[patent_doc_number] => 20170002041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'NOVEL ULTRASHORT HYDROPHOBIC PEPTIDES THAT SELF-ASSEMBLE INTO NANOFIBROUS HYDROGELS AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 15/039922
[patent_app_country] => US
[patent_app_date] => 2014-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18918
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15039922
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/039922 | NOVEL ULTRASHORT HYDROPHOBIC PEPTIDES THAT SELF-ASSEMBLE INTO NANOFIBROUS HYDROGELS AND THEIR USES | Nov 27, 2014 | Abandoned |
Array
(
[id] => 13672713
[patent_doc_number] => 20160375090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => METHOD AND COMPOSITION FOR SYNCHRONIZING TIME OF INSEMINATION IN GILTS
[patent_app_type] => utility
[patent_app_number] => 15/039728
[patent_app_country] => US
[patent_app_date] => 2014-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14261
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15039728
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/039728 | METHOD AND COMPOSITION FOR SYNCHRONIZING TIME OF INSEMINATION IN GILTS | Nov 25, 2014 | Abandoned |
Array
(
[id] => 10767847
[patent_doc_number] => 20160114002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'COMPOSITIONS COMPRISING PLANT PROTEINS AND METHODS FOR PREVENTION OF METABOLIC AND CARDIOVASCULAR PATHOLOGIES IN PATIENT WITH CARDIOMETABOLIC RISK, INCLUDING HYPERGLYCEMIA'
[patent_app_type] => utility
[patent_app_number] => 14/549709
[patent_app_country] => US
[patent_app_date] => 2014-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5313
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14549709
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/549709 | COMPOSITIONS COMPRISING PLANT PROTEINS AND METHODS FOR PREVENTION OF METABOLIC AND CARDIOVASCULAR PATHOLOGIES IN PATIENT WITH CARDIOMETABOLIC RISK, INCLUDING HYPERGLYCEMIA | Nov 20, 2014 | Abandoned |
Array
(
[id] => 10248387
[patent_doc_number] => 20150133384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'C-Terminal Fragments of Glucagon-Like Peptide-1 (GLP-1)'
[patent_app_type] => utility
[patent_app_number] => 14/539578
[patent_app_country] => US
[patent_app_date] => 2014-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8196
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14539578
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/539578 | C-terminal fragments of glucagon-like peptide-1 (GLP-1) | Nov 11, 2014 | Issued |
Array
(
[id] => 11092304
[patent_doc_number] => 20160289272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'ANTIMICROBIAL AGENTS AND THEIR USE IN THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/034948
[patent_app_country] => US
[patent_app_date] => 2014-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 31783
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15034948
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/034948 | Antimicrobial agents and their use in therapy | Nov 5, 2014 | Issued |
Array
(
[id] => 10782995
[patent_doc_number] => 20160129151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'PROTEIN BASED MATERIALS'
[patent_app_type] => utility
[patent_app_number] => 14/534869
[patent_app_country] => US
[patent_app_date] => 2014-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 5835
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14534869
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/534869 | PROTEIN BASED MATERIALS | Nov 5, 2014 | Abandoned |
Array
(
[id] => 11025108
[patent_doc_number] => 20160222063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'NOVEL POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/029248
[patent_app_country] => US
[patent_app_date] => 2014-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18620
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15029248
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/029248 | Polypeptide ligands specific for plasma kallikrein | Oct 27, 2014 | Issued |
Array
(
[id] => 9895152
[patent_doc_number] => 20150050351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-19
[patent_title] => 'STEREOISOMER PEPTIDES, THEIR POLYMER CONJUGATES, THEIR ENCAPSULATION INTO NANOPARTICLES, AND USES THEREOF FOR THE TREATMENT OF DISEASES CAUSED BY ABNORMAL ANGIOGENESIS.'
[patent_app_type] => utility
[patent_app_number] => 14/521600
[patent_app_country] => US
[patent_app_date] => 2014-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 37953
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14521600
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/521600 | Stereoisomer peptides, their polymer conjugates, their encapsulation into nanoparticles, and uses thereof for the treatment of diseases caused by abnormal angiogenesis | Oct 22, 2014 | Issued |
Array
(
[id] => 11059617
[patent_doc_number] => 20160256580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'MINI-GASTRIN ANALOGUE, IN PARTICULAR FOR USE IN CCK2 RECEPTOR POSITIVE TUMOUR DIAGNOSIS AND/OR TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/034943
[patent_app_country] => US
[patent_app_date] => 2014-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2491
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15034943
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/034943 | Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment | Oct 22, 2014 | Issued |
Array
(
[id] => 9858386
[patent_doc_number] => 20150038402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'MODULATORS OF PROTEASE ACTIVATED RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 14/519383
[patent_app_country] => US
[patent_app_date] => 2014-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20142
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14519383
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/519383 | Modulators of protease activated receptors | Oct 20, 2014 | Issued |
Array
(
[id] => 11061021
[patent_doc_number] => 20160257983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'N-GLYCOSYLATION OF PEPTIDES AND PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/029730
[patent_app_country] => US
[patent_app_date] => 2014-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15444
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15029730
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/029730 | N-GLYCOSYLATION OF PEPTIDES AND PROTEINS | Oct 14, 2014 | Abandoned |
Array
(
[id] => 11054434
[patent_doc_number] => 20160251396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'METHODS FOR SEPARATING AND PURIFYING ENDOGENOUS, EXOGENOUS AND RECOMBINANT PROTEINS/PEPTIDES FROM PLANTS AND ANIMALS USING AQUEOUS-FREE, ANHYDROUS STRATEGIES'
[patent_app_type] => utility
[patent_app_number] => 15/027884
[patent_app_country] => US
[patent_app_date] => 2014-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7255
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15027884
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/027884 | Methods for separating and purifying endogenous, exogenous and recombinant proteins/peptides from plants and animals using aqueous-free, anhydrous strategies | Oct 8, 2014 | Issued |
Array
(
[id] => 16414519
[patent_doc_number] => 10822395
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-03
[patent_title] => Modified anti-inflammatory proteins and method of use
[patent_app_type] => utility
[patent_app_number] => 15/023165
[patent_app_country] => US
[patent_app_date] => 2014-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 12936
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15023165
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/023165 | Modified anti-inflammatory proteins and method of use | Sep 17, 2014 | Issued |
Array
(
[id] => 11023734
[patent_doc_number] => 20160220689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'MACROMOLECULES OF DENDRIMER-PLATINUM CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 14/917915
[patent_app_country] => US
[patent_app_date] => 2014-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30961
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14917915
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/917915 | MACROMOLECULES OF DENDRIMER-PLATINUM CONJUGATES | Sep 9, 2014 | Abandoned |
Array
(
[id] => 11277072
[patent_doc_number] => 09493546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-15
[patent_title] => 'Fibronectin based scaffold domain proteins that bind to myostatin'
[patent_app_type] => utility
[patent_app_number] => 14/481641
[patent_app_country] => US
[patent_app_date] => 2014-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 18
[patent_no_of_words] => 56963
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14481641
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/481641 | Fibronectin based scaffold domain proteins that bind to myostatin | Sep 8, 2014 | Issued |
Array
(
[id] => 16681721
[patent_doc_number] => 10941187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => GLP-1, exendin-4, peptide analogs and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/470528
[patent_app_country] => US
[patent_app_date] => 2014-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 45
[patent_no_of_words] => 23996
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14470528
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/470528 | GLP-1, exendin-4, peptide analogs and uses thereof | Aug 26, 2014 | Issued |